Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies

References

• LaumannEOPaikARosenRCSexual dysfunction in the United States: prevalence and predictorsJAMA1999281653754410022110
   PubMed Web of Science ®Google Scholar
• WaldingerMDPsychiatric disorders and sexual dysfunctionHandb Clin Neurol201513046948926003261
   PubMedGoogle Scholar
• AtlantisESullivanTBidirectional association between depression and sexual dysfunction: a systematic review and meta-analysisJ Sex Med2012961497150722462756
   PubMed Web of Science ®Google Scholar
• ClaytonAHThe impact of antidepressant-associated sexual dysfunction on treatment adherence in patients with major depressive disorderCurr Psychiatr Rev201394293301
   Google Scholar
• ClaytonAHReddySFochtKMusgnungJFayyadRAn evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placeboJ Sex Med201310376877622905811
   PubMed Web of Science ®Google Scholar
• ClaytonAKornsteinSPrakashAMallinckrodtCWohlreichMChanges in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorderJ Sex Med200744 Pt 191792917627739
   PubMed Web of Science ®Google Scholar
• ClaytonAHCroftHAHandiwalaLAntidepressants and sexual dysfunction: mechanisms and clinical implicationsPostgrad Med20141262919924685972
   PubMed Web of Science ®Google Scholar
• ClaytonAHKennedySHEdwardsJBGallipoliSReedCRThe effect of vilazodone on sexual function during the treatment of major depressive disorderJ Sex Med201310102465247623216998
   PubMed Web of Science ®Google Scholar
• ClaytonAHLocklearJCSvedsäterHMcIntyreRSSexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarateCNS Spectr201419218219624067192
   PubMed Web of Science ®Google Scholar
• CasperRCRedmondDEJrKatzMMSchafferCBDavisJMKoslowSHSomatic symptoms in primary affective disorder: presence and relationship to the classification of depressionArch Gen Psychiatry19854211109811043863548
   PubMed Web of Science ®Google Scholar
• KaplanHSAnxiety and sexual dysfunctionJ Clin Psychiatry198849Suppl21253170497
   PubMed Web of Science ®Google Scholar
• KesslerRCChiuWTDemlerOMerikangasKRWaltersEEPrevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry200562661762715939839
   PubMed Web of Science ®Google Scholar
• KesslerRCBerglundPDemlerOJinRMerikangasKRWaltersEELifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry200562659360215939837
   PubMed Web of Science ®Google Scholar
• KendurkarAKaurBMajor depressive disorder, obsessive-compulsive disorder, and generalized anxiety disorder: do the sexual dysfunctions differ?Prim Care Companion J Clin Psychiatry200810429930518787674
   PubMedGoogle Scholar
• McGahueyCAGelenbergAJLaukesCAThe Arizona Sexual Experience Scale (ASEX): reliability and validityJ Sex Marital Ther2000261254010693114
   PubMed Web of Science ®Google Scholar
• OlivierBChanJSSnoerenEMDifferences in sexual behaviour in male and female rodents: role of serotoninCurr Top Behav Neurosci20118153621374021
   PubMedGoogle Scholar
• ClaytonAHMcGarveyELClavetGJPiazzaLComparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ)Psychopharmacol Bull19973347477539493487
   PubMedGoogle Scholar
• KhanACutlerAJKajdaszDKA randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorderJ Clin Psychiatry201172444144721527122
   PubMed Web of Science ®Google Scholar
• RickelsKAthanasiouMRobinsonDSGibertiniMWhalenHReedCREvidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trialJ Clin Psychiatry200970332633319284933
   PubMed Web of Science ®Google Scholar
• RobinsonDSKajdaszDKGallipoliSWhalenHWamilAReedCRA 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorderJ Clin Psychopharmacol201131564364621869687
   PubMed Web of Science ®Google Scholar
• AdamecRBartoszykGDBurtonPEffects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in ratsEur J Pharmacol20045041–2657715507223
   PubMed Web of Science ®Google Scholar
• HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508
   PubMed Web of Science ®Google Scholar
• GommollCForeroGMathewsMVilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose studyInt Clin Psychopharmacol201530629730626291335
   PubMed Web of Science ®Google Scholar
• DurgamSGommollCForeroGEfficacy and safety of vilazodone in patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled, flexible-dose trialJ Clin Psychiatry2016
   Google Scholar
• GommollCDurgamSMathewsMA double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorderDepress Anxiety201532645145925891440
   PubMed Web of Science ®Google Scholar
• GuyWThe clinician global severity and impression scalesECDEU Assessment Manual for PsychopharmacologyRockville (MD)National Institute of Mental Health1976218222
   Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• KellerAMcGarveyELClaytonAHReliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14)J Sex Marital Ther2006321435216234225
   PubMed Web of Science ®Google Scholar
• KennedySHRizviSSexual dysfunction, depression, and the impact of antidepressantsJ Clin Psychopharmacol200929215716419512977
   PubMed Web of Science ®Google Scholar
• BodingerLHermeshHAizenbergDSexual function and behavior in social phobiaJ Clin Psychiatry2002631087487912416596
   PubMed Web of Science ®Google Scholar
• FigueiraIPossidenteEMarquesCHayesKSexual dysfunction: a neglected complication of panic disorder and social phobiaArch Sex Behav200130436937711446198
   PubMed Web of Science ®Google Scholar
• HeimbergRGBarlowDHPsychosocial treatments for social phobiaPsychosomatics198829127373277216
   PubMed Web of Science ®Google Scholar
• LearyMRDobbinsSESocial anxiety, sexual behavior, and contraceptive useJ Pers Soc Psychol1983456134713546663447
   PubMed Web of Science ®Google Scholar
• MonteiroWONoshirvaniHFMarksIMLelliottPTAnorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trialBr J Psychiatry19871511071123315086
   PubMed Web of Science ®Google Scholar
• LetourneauEJSchewePAFruehBCPreliminary evaluation of sexual problems in combat veterans with PTSDJ Trauma Stress19971011251329018683
   PubMed Web of Science ®Google Scholar
• Al-AzzawiFBitzerJBrandenburgUTherapeutic options for postmenopausal female sexual dysfunctionClimacteric201013210312019958161
   PubMed Web of Science ®Google Scholar
• HoekstraTLesman-LeegteILuttikMLSexual problems in elderly male and female patients with heart failureHeart201298221647165222875738
   PubMed Web of Science ®Google Scholar
• MironeVSessaAGiulianoFCurrent benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse eventsInt J Clin Pract20116591005101321718399
   PubMed Web of Science ®Google Scholar
• WylieKKenneyGSexual dysfunction and the ageing maleMaturitas2010651232720015601
   PubMed Web of Science ®Google Scholar
• ClaytonAHGommollCChenDNunezRMathewsMSexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trialInt Clin Psychopharmacol201530421622326039688
   PubMed Web of Science ®Google Scholar
• LandenMHogbergPThaseMEIncidence of sexual side effects in refractory depression during treatment with citalopram or paroxetineJ Clin Psychiatry200566110010615669895
   PubMed Web of Science ®Google Scholar
• MontejoALLlorcaGIzquierdoJARico-VillademorosFIncidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual DysfunctionJ Clin Psychiatry200162Suppl 3102111229449
   PubMed Web of Science ®Google Scholar
• JacobsenPLMahableshwarkarARPaloWAChenYDragheimMClaytonAHTreatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysisCNS Spectr Epub20151117
   Web of Science ®Google Scholar